Team:TCU Taiwan/Safety
From 2014.igem.org
(Difference between revisions)
(26 intermediate revisions not shown) | |||
Line 66: | Line 66: | ||
}); | }); | ||
</script> | </script> | ||
- | + | <script type="text/javascript"><!-- | |
+ | Image0 = new Image(100,50); Image0.src = "https://static.igem.org/mediawiki/2014/a/aa/TCU-Contact-bot1.png"; | ||
+ | // --></script> | ||
<!--End Analytics--> | <!--End Analytics--> | ||
<body style="background:#ffffff"> | <body style="background:#ffffff"> | ||
Line 105: | Line 107: | ||
<li><a href="#" style="cursor:default"><font size="5">Team</font></a> | <li><a href="#" style="cursor:default"><font size="5">Team</font></a> | ||
<ul> | <ul> | ||
- | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/Team"><font size="3"> | + | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/Team"><font size="3">Members</font></a></li> |
+ | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/Achievements"><font size="3">Achievements</font></a></li> | ||
<li><a href="https://igem.org/Team.cgi?id=1473" target="_blank"><font size="3">Official Team Profile</font></a></li> | <li><a href="https://igem.org/Team.cgi?id=1473" target="_blank"><font size="3">Official Team Profile</font></a></li> | ||
<li><a href="https://2014.igem.org/Team:TCU_Taiwan/Contact"><font size="3">Contact</font></a></li> | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/Contact"><font size="3">Contact</font></a></li> | ||
Line 119: | Line 122: | ||
<li><a href="#" style="cursor:default"><font size="5">Project</font></a> | <li><a href="#" style="cursor:default"><font size="5">Project</font></a> | ||
<ul> | <ul> | ||
- | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/Project"><font size="3"> | + | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/Project"><font size="3">Introduction</font></a></li> |
<li><a href="https://2014.igem.org/Team:TCU_Taiwan/Parts"><font size="3">Parts</font></a></li> | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/Parts"><font size="3">Parts</font></a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/SystemDesign"><font size="3">System Design</font></a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/M13Phage"><font size="3">M13 Phage</font></a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/CRISPR"><font size="3">CRISPR</font></a></li> | ||
+ | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/FutureWorks"><font size="3">Future Works</font></a></li> | ||
<li><a href="https://2014.igem.org/Team:TCU_Taiwan/HumanPratics"><font size="3">Human Pratics</font></a></li> | <li><a href="https://2014.igem.org/Team:TCU_Taiwan/HumanPratics"><font size="3">Human Pratics</font></a></li> | ||
</ul> | </ul> | ||
Line 172: | Line 179: | ||
<!--welcome box --> | <!--welcome box --> | ||
- | <tr> <td | + | <tr> <td width="45%" height="5px" colspan="3"> </td></tr> |
<!-- end welcome box --> | <!-- end welcome box --> | ||
Line 249: | Line 256: | ||
<br> | <br> | ||
<p class="qbody"><span class="qnum"><font size="3" face="Verdana" color="#90B849"><strong>a)</strong></font></span><strong><font size="3" face="Verdana" color="#333">What is the Safety Level of your lab? (Use the <a href="https://2014.igem.org/Safety_Hub#rgbsl" target="_blank">WHO numbering system</a>, in which Level 4 is used for the most dangerous organisms.)</font></strong><font size="3" face="Verdana" color="#333"></font></p> | <p class="qbody"><span class="qnum"><font size="3" face="Verdana" color="#90B849"><strong>a)</strong></font></span><strong><font size="3" face="Verdana" color="#333">What is the Safety Level of your lab? (Use the <a href="https://2014.igem.org/Safety_Hub#rgbsl" target="_blank">WHO numbering system</a>, in which Level 4 is used for the most dangerous organisms.)</font></strong><font size="3" face="Verdana" color="#333"></font></p> | ||
- | <div class="wrapper" style="background-color: white;"><font size="3" face="Verdana" color="#333"><ul style="margin-left: 1em;"><li><a href="https://2014.igem.org/Safety_Hub#safety_levels" target="_blank">Level 2</a> (moderate risk, | + | <div class="wrapper" style="background-color: white;"><font size="3" face="Verdana" color="#333"><ul style="margin-left: 1em;"><li><a href="https://2014.igem.org/Safety_Hub#safety_levels" target="_blank">Level 2</a> (moderate risk, ≌ WHO BSL 2)</li></ul></font></div> |
<br> | <br> | ||
<p class="qbody"><span class="qnum"><font size="3" face="Verdana" color="#90B849"><strong>b)</strong></font></span><strong><font size="3" face="Verdana" color="#333">According to the WHO Biosafety Manual, what is the BioSafety Level rating of your lab? </font></strong></p> | <p class="qbody"><span class="qnum"><font size="3" face="Verdana" color="#90B849"><strong>b)</strong></font></span><strong><font size="3" face="Verdana" color="#333">According to the WHO Biosafety Manual, what is the BioSafety Level rating of your lab? </font></strong></p> | ||
<div class="wrapper" style="background-color: white;"><font size="3" face="Verdana" color="#333"><ul style="margin-left: 1em;"><li>Laminar flow hood/biosafety cabinet with open front | <div class="wrapper" style="background-color: white;"><font size="3" face="Verdana" color="#333"><ul style="margin-left: 1em;"><li>Laminar flow hood/biosafety cabinet with open front | ||
</li></ul></font> | </li></ul></font> | ||
- | <p>< | + | <p><table width="25%" border="0" cellspacing="0" cellpadding="0"> |
+ | <tr> | ||
+ | <td><span class="wrapper" style="background-color: white;"><img src="https://static.igem.org/mediawiki/2014/8/8d/TCU_IMG_20140928_160142.jpg" width="100%"></span></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td align="center"><font color="#333" size="2" face="Verdana">Cute BoBo looks back with a smile.</font></td> | ||
+ | </tr> | ||
+ | </table></p> | ||
</div> | </div> | ||
<br> | <br> | ||
Line 326: | Line 340: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>E.coli DH5α</td> | + | <td><em>E.coli</em> DH5α</td> |
<td>1</td> | <td>1</td> | ||
<td>WHO</td> | <td>WHO</td> | ||
Line 337: | Line 351: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td>E.coli NEB10 β</td> | + | <td><em>E.coli</em> NEB10 β</td> |
<td>1</td> | <td>1</td> | ||
<td>WHO</td> | <td>WHO</td> | ||
Line 381: | Line 395: | ||
<fieldset> | <fieldset> | ||
- | <legend class="qnum" align="center"><font face="Trebuchet MS" size="6" color="#90B849">5.Risks of | + | <legend class="qnum" align="center"><font face="Trebuchet MS" size="6" color="#90B849">5.Risks of Our Project Now</font></legend> |
<br> | <br> | ||
Line 416: | Line 430: | ||
<fieldset> | <fieldset> | ||
- | <legend class="qnum" align="center"><font face="Trebuchet MS" size="6" color="#90B849">6.Risks of | + | <legend class="qnum" align="center"><font face="Trebuchet MS" size="6" color="#90B849">6.Risks of Our Project in the Future</font></legend> |
<br> | <br> | ||
<p>What would happen if all your dreams came true, and your project grew from a small lab study into a commercial/industrial/medical product that was used by many people? We invite you to speculate broadly and discuss possibilities, rather than providing definite answers. Even if the product is "safe", please discuss possible risks and how they could be addressed, rather than simply saying that there are no risks at all.</p> | <p>What would happen if all your dreams came true, and your project grew from a small lab study into a commercial/industrial/medical product that was used by many people? We invite you to speculate broadly and discuss possibilities, rather than providing definite answers. Even if the product is "safe", please discuss possible risks and how they could be addressed, rather than simply saying that there are no risks at all.</p> | ||
Line 423: | Line 437: | ||
<p class="qbody"><span class="qnum"><font size="3" face="Verdana" color="#90B849"><strong>a)</strong></font></span><font size="3" face="Verdana" color="#333"><strong>What <i>new</i> risks might arise from your project's growth?</strong></font></p> | <p class="qbody"><span class="qnum"><font size="3" face="Verdana" color="#90B849"><strong>a)</strong></font></span><font size="3" face="Verdana" color="#333"><strong>What <i>new</i> risks might arise from your project's growth?</strong></font></p> | ||
<p class="qbody"><strong><font size="3" face="Verdana" color="#333">Also, what risks might arise if the <i>knowledge</i> you generate or the <i>methods</i> you develop became widely available?</font></strong><font size="3" face="Verdana" color="#333"></font></p> | <p class="qbody"><strong><font size="3" face="Verdana" color="#333">Also, what risks might arise if the <i>knowledge</i> you generate or the <i>methods</i> you develop became widely available?</font></strong><font size="3" face="Verdana" color="#333"></font></p> | ||
- | <div class="wrapper" style="background-color: white; | + | <div class="wrapper" style="background-color: white;"><ul style="margin-left: 1em;"><li><font color="#333" size="3" face="Verdana">Injecting phage into human body may cause some unknown danger.</font></li><li><font color="#333" size="3" face="Verdana"> |
- | May speed up | + | May speed up <em>E.coli</em> to develop "resistance" to phage.</font></li></ul></div> |
<br> | <br> | ||
<br> | <br> | ||
<p class="qbody"><span class="qnum"><font size="3" face="Verdana" color="#90B849"><strong>b)</strong></font></span><font size="3" face="Verdana" color="#333"><strong>Does your project currently include any design features to reduce risks? Or, if you did all the future work to make your project grow into a popular product, would you plan to design any new features to minimize risks?Such features are not required for an iGEM project, but many teams choose to explore them.</strong></font></p> | <p class="qbody"><span class="qnum"><font size="3" face="Verdana" color="#90B849"><strong>b)</strong></font></span><font size="3" face="Verdana" color="#333"><strong>Does your project currently include any design features to reduce risks? Or, if you did all the future work to make your project grow into a popular product, would you plan to design any new features to minimize risks?Such features are not required for an iGEM project, but many teams choose to explore them.</strong></font></p> | ||
- | <div class="wrapper" style="background-color: white;"><font size="3" face="Verdana" color="#333"><ul style="margin-left: 1em;"><li>We thought to change phage's | + | <div class="wrapper" style="background-color: white;"><font size="3" face="Verdana" color="#333"><ul style="margin-left: 1em;"><li>We thought to change phage's coat protein so we can access our phage's infection ability. But this is beyond our current project.</li></ul></font></div> |
<br> | <br> | ||
</fieldset> | </fieldset> | ||
Line 437: | Line 451: | ||
<br> | <br> | ||
<br> | <br> | ||
- | <p class="qbody"><font size="3" face="Verdana" color="#333"><img src="https://static.igem.org/mediawiki/2014/f/f5/TCU_Health_Work.png" style=" float: left; margin-right: 5px;" width="135">Emergency Medical Technician (EMT) are terms used in some countries to denote a <a href="http://en.wikipedia.org/wiki/Health_professional" target="_blank">health care provider</a> of <a href="http://en.wikipedia.org/wiki/Emergency_medical_services" target="_blank">emergency medical services</a>.EMTs are clinicians, trained to respond quickly to emergency situations regarding medical issues, traumatic injuries and accident scenes.</font></p> | + | <p class="qbody"><font size="3" face="Verdana" color="#333"><img src="https://static.igem.org/mediawiki/2014/f/f5/TCU_Health_Work.png" style=" float: left; margin-right: 5px;" width="135"><img src="https://static.igem.org/mediawiki/2014/4/48/TCU_SAFETY_10489164_882403321776060_1876998885_n.jpg" width="100" style=" float: right; margin-right: 5px;margin-left: 5px;">Emergency Medical Technician (EMT) are terms used in some countries to denote a <a href="http://en.wikipedia.org/wiki/Health_professional" target="_blank">health care provider</a> of <a href="http://en.wikipedia.org/wiki/Emergency_medical_services" target="_blank">emergency medical services</a>.EMTs are clinicians, trained to respond quickly to emergency situations regarding medical issues, traumatic injuries and accident scenes.</font></p> |
<p class="qbody"><font size="3" face="Verdana" color="#333">House,one of our team members,is a Emergency Medical Technician.He got the EMT-1(EMT-B) Licence and he volunteered for Hualien County Fire Department.He can handle every medical emergencies for team members in daily life.</font></p> | <p class="qbody"><font size="3" face="Verdana" color="#333">House,one of our team members,is a Emergency Medical Technician.He got the EMT-1(EMT-B) Licence and he volunteered for Hualien County Fire Department.He can handle every medical emergencies for team members in daily life.</font></p> | ||
+ | |||
<div class="wrapper" style="background-color: white;"></div> | <div class="wrapper" style="background-color: white;"></div> | ||
Line 452: | Line 467: | ||
<li>We choose phage as our vector for the CRISPR system because of the high specificity. Each kind of phage will only infect one kind of bacteria efficiently. </li><br> | <li>We choose phage as our vector for the CRISPR system because of the high specificity. Each kind of phage will only infect one kind of bacteria efficiently. </li><br> | ||
<li>To avoid the co-effect of phage infection, we choose the “phagemid-helper phage” system for phage display. This system creates progeny who cannot produce next generation along. Thus, our project will not cause additional phage remaining in the environment.</li><br> | <li>To avoid the co-effect of phage infection, we choose the “phagemid-helper phage” system for phage display. This system creates progeny who cannot produce next generation along. Thus, our project will not cause additional phage remaining in the environment.</li><br> | ||
- | + | ||
<li>We design our CRISPR’s target as antibiotics resistance gene. So it will not influence bacteria’s growth as long as we don’t add antibiotics. We did this because we want the situation is always under control. (We DO NOT want to simply kill those bacteria, we just want to remove their resistance and make them under our control.)</li> | <li>We design our CRISPR’s target as antibiotics resistance gene. So it will not influence bacteria’s growth as long as we don’t add antibiotics. We did this because we want the situation is always under control. (We DO NOT want to simply kill those bacteria, we just want to remove their resistance and make them under our control.)</li> | ||
</ol></font> | </ol></font> | ||
Line 577: | Line 592: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td | + | <td> |
</tr> | </tr> | ||
- | <tr> <td colspan="3" | + | <tr> |
- | + | <td colspan="3" height="10px" bgcolor="#FFF2B5" align="center"> <font face="Trebuchet MS" size="6" color="#A66B38">Trogene Horse's Hometown</font> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | |||
<tr> | <tr> | ||
- | <td | + | <td colspan="3" height="10px"> |
- | < | + | </tr> |
+ | <tr> | ||
+ | <td colspan="3" align="center"> <iframe width="720" height="482" frameborder="0" src="http://files.slidemypics.com/app/js/iframe.html?bg_color=ffffff&hash=1492090f52dc147797a13b1ca1459908&r=0.6832032252568752"></iframe> | ||
+ | </tr> | ||
- | + | <!--safety content--> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
</table> | </table> | ||
- | + | <table width="100%" border="0" cellspacing="0" cellpadding="0"> | |
- | <table width=" | + | |
<tr> | <tr> | ||
- | <td | + | <td height="30"> </td> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | |||
- | |||
<tr> | <tr> | ||
<td><img src="https://static.igem.org/mediawiki/2014/c/c1/TCU-Line.png" width="100%"></td> | <td><img src="https://static.igem.org/mediawiki/2014/c/c1/TCU-Line.png" width="100%"></td> | ||
Line 670: | Line 618: | ||
<tr align="center" bgcolor="#F2DE79" height="150px" style="width:150px"> | <tr align="center" bgcolor="#F2DE79" height="150px" style="width:150px"> | ||
<td width="15%" align="center"><div id="gotop">^</div> | <td width="15%" align="center"><div id="gotop">^</div> | ||
- | <a href="https://2014.igem.org/Team:TCU_Taiwan/Contact" title="Contact Us"><img src="https://static.igem.org/mediawiki/2014/8/84/TCU-Contact-bot.png" width="80" onMouseMove="this.src= | + | <a href="https://2014.igem.org/Team:TCU_Taiwan/Contact" title="Contact Us"><img src="https://static.igem.org/mediawiki/2014/8/84/TCU-Contact-bot.png" width="80" onMouseMove="this.src=Image0.src;" onMouseOut="this.src='https://static.igem.org/mediawiki/2014/8/84/TCU-Contact-bot.png'"></a> |
<br><br> | <br><br> | ||
<a href="mailto: tcutaiwan@gmail.com" target="_blank" title="Gmail"><img src="https://static.igem.org/mediawiki/2014/c/c4/TCU%E3%84%A6Gmail.png" width="30"></a> | <a href="mailto: tcutaiwan@gmail.com" target="_blank" title="Gmail"><img src="https://static.igem.org/mediawiki/2014/c/c4/TCU%E3%84%A6Gmail.png" width="30"></a> | ||
Line 677: | Line 625: | ||
<td width="0.5px" align="center" bgcolor="#A66B38"> </td> | <td width="0.5px" align="center" bgcolor="#A66B38"> </td> | ||
<td> | <td> | ||
- | + | ||
- | + | <table width="70%" border="0" cellspacing="0" cellpadding="0" align="center" style="background-color:#F2DE79"> | |
- | + | ||
- | <table width="70%" border="0" cellspacing="0" cellpadding="0" align="center" | + | |
<tr align="center"> | <tr align="center"> | ||
<td><font size="2" face="Verdana" color="#F2DE79" id="Members">Team Members</font></td> | <td><font size="2" face="Verdana" color="#F2DE79" id="Members">Team Members</font></td> | ||
Line 697: | Line 643: | ||
<td><a href="https://2014.igem.org/Team:TCU_Taiwan/HumanPratics" title="Human Pratics"><img src="https://static.igem.org/mediawiki/2014/d/dd/TCU-Human-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Pratics.color='#333'" onMouseOut="this.width=this.width/1.1;Pratics.color='#F2DE79'"></a></td> | <td><a href="https://2014.igem.org/Team:TCU_Taiwan/HumanPratics" title="Human Pratics"><img src="https://static.igem.org/mediawiki/2014/d/dd/TCU-Human-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Pratics.color='#333'" onMouseOut="this.width=this.width/1.1;Pratics.color='#F2DE79'"></a></td> | ||
<td><a href="https://2014.igem.org/Team:TCU_Taiwan/Modeling" title="Modeling"><img src="https://static.igem.org/mediawiki/2014/3/3f/TCU-Modeling-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Modeling.color='#333'" onMouseOut="this.width=this.width/1.1;Modeling.color='#F2DE79'"></a></td> | <td><a href="https://2014.igem.org/Team:TCU_Taiwan/Modeling" title="Modeling"><img src="https://static.igem.org/mediawiki/2014/3/3f/TCU-Modeling-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Modeling.color='#333'" onMouseOut="this.width=this.width/1.1;Modeling.color='#F2DE79'"></a></td> | ||
- | <td><a href="https://2014.igem.org/Team:TCU_Taiwan/Safety" title="Safety"><img src="https://static.igem.org/mediawiki/2014/2/21/TCU-Safety-logo.png" width="100" onMouseOver="this.width=this.width*1.1; | + | <td><a href="https://2014.igem.org/Team:TCU_Taiwan/Safety" title="Safety"><img src="https://static.igem.org/mediawiki/2014/2/21/TCU-Safety-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Safety.color='#333'" onMouseOut="this.width=this.width/1.1;Safety.color='#F2DE79'"></a></td> |
<td><a href="https://2014.igem.org/Team:TCU_Taiwan/Notebook" title="Notebook"><img src="https://static.igem.org/mediawiki/2014/2/25/TCU-Notebook-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Notebook.color='#333'" onMouseOut="this.width=this.width/1.1;Notebook.color='#F2DE79'"></a></td> | <td><a href="https://2014.igem.org/Team:TCU_Taiwan/Notebook" title="Notebook"><img src="https://static.igem.org/mediawiki/2014/2/25/TCU-Notebook-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Notebook.color='#333'" onMouseOut="this.width=this.width/1.1;Notebook.color='#F2DE79'"></a></td> | ||
<td><a href="https://2014.igem.org/Team:TCU_Taiwan/Attributions" title="Attributions"><img src="https://static.igem.org/mediawiki/2014/5/51/TCU-Attributions-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Attributions.color='#333'" onMouseOut="this.width=this.width/1.1;Attributions.color='#F2DE79'"></a></td> | <td><a href="https://2014.igem.org/Team:TCU_Taiwan/Attributions" title="Attributions"><img src="https://static.igem.org/mediawiki/2014/5/51/TCU-Attributions-logo.png" width="100" onMouseOver="this.width=this.width*1.1;Attributions.color='#333'" onMouseOut="this.width=this.width/1.1;Attributions.color='#F2DE79'"></a></td> |
Latest revision as of 19:55, 17 October 2014